Novavax Inc (NASDAQ:NVAX)

1.72
Delayed Data
As of May 24
 +0.02 / +1.18%
Today’s Change
0.90
Today|||52-Week Range
2.75
+38.71%
Year-to-Date
Weekly CFO Buys Highlight
May 20 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close1.70
Today’s open1.69
Day’s range1.68 - 1.75
Volume3,338,828
Average volume (3 months)8,348,964
Market cap$645.0M
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+38.83%
Earnings growth (this year)+16.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+103.06%
P/E ratioNM
Price/Sales11.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.01-0.29%
EDGEEdge Therapeutics In...+0.03+3.18%
BTXBioTime Inc-0.04-1.78%
RIGLRigel Pharmaceutical...0.000.00%
Data as of 8:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$31.2M
Annual profit (last year)-$183.8M
Net profit margin-589.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts